BioNTech (BNTX)
(Delayed Data from NSDQ)
$103.91 USD
-0.76 (-0.73%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $105.98 +2.07 (1.99%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Key Expected Earnings Data
| Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
|---|---|---|---|
| 11/03/2025
Time: BMO |
9/2025 | $0.75 | 42.15% |
Earnings Summary
For their last quarter, BioNTech (BNTX) reported earnings of -$1.82 per share, missing the Zacks Consensus Estimate of -$1.31 per share. This reflects a negative earnings surprise of 38.93%. Look out for BNTX's next earnings release on November 03, 2025. For the next earning release, we expect the company to report earnings of $0.75 per share, reflecting a year-over-year decrease of 15.73%.
Earnings History
Price & Consensus
Zacks News for BNTX
Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pfizer's Q3 Non-Oncology Performance: Here's What to Expect
BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
BNTX FAQs
BioNTech SE Sponsored ADR (BNTX) has announced they will report their next quarter earnings on November 03, 2025. For the next earning release, we expect the company to report earnings of $0.75 per share, reflecting a year-over-year decrease of -15.73%.
BioNTech SE Sponsored ADR has announced they will report their previous quarter earnings after the close of the market on November 03, 2025.
The Zacks Consensus Estimate for BioNTech SE Sponsored ADR (BNTX) for the quarter ending in September 2025 is $0.75 a share. We expect BioNTech SE Sponsored ADR to miss by 42.15%.
In the earnings report for the quarter ending in September 2024, BioNTech SE Sponsored ADR (BNTX) announced earnings of $0.89 per share versus the Zacks Consensus Estimate of $-1.26 per share, representing a surprise of -170.63%.
